Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is adenoid cystic carcinoma?
Adenoid cystic carcinoma (ACC) is an uncommon cancer that arises in secretory glands — most often the salivary glands of the head and neck, but also the tear glands, the windpipe, the breast, and glands in the skin and elsewhere. It is known for a particular combination of traits: it usually grows slowly, yet it is relentless, with a strong tendency to come back over many years and to spread to distant organs, especially the lungs, sometimes a decade or more after the original treatment. Its most distinctive feature is perineural invasion — the cancer's habit of tracking along the sheaths of nerves, creeping outward from the visible tumor in a way that is invisible to the naked eye and easy to underestimate. This is why ACC can cause symptoms such as pain, numbness, or facial weakness out of proportion to the size of the lump, and why treatment must account for disease extending well beyond what can be seen or felt. Because the cancer follows nerves and infiltrates surrounding tissue, surgery alone often leaves microscopic disease behind, so radiation is a standard partner — given after surgery to treat the wider zone, including the paths of nearby nerves, and used as the main treatment when a tumor cannot be removed. ACC is relatively resistant to ordinary chemotherapy, so for many years particle-beam radiation (using neutrons or protons) has been studied as a way to deliver a more powerful or more precise dose, and the cornerstone of care remains the careful combination of complete surgery with radiation, followed by long-term monitoring.
The main types
Doctors group adenoid cystic carcinoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Salivary gland adenoid cystic carcinoma | The most common location — in the major salivary glands (such as the parotid or submandibular) or the many minor glands lining the mouth and throat; treated with surgery and radiation, with attention to the facial and other nearby nerves. |
| Lacrimal (tear) gland adenoid cystic carcinoma | Arises in the gland that makes tears, near the eye; treatment balances controlling the cancer with preserving vision and the eye, often using precise radiation such as protons. |
| Airway adenoid cystic carcinoma (trachea/bronchus) | Grows in the windpipe or large airways and can creep a long way along them; surgery is used when possible, and radiation is important because clear margins are hard to achieve. |
| Breast and other-site adenoid cystic carcinoma | A rare form in the breast that, unlike most breast cancers, tends to behave more favorably; ACC can also arise in the skin and other glands, treated with surgery and radiation as the site allows. |
Staging, in plain terms
Adenoid cystic carcinoma is staged using the TNM system that fits the part of the body where it arose — most often the head-and-neck salivary staging system, which considers the size and local extent of the tumor (T), whether nearby lymph nodes are involved (N, which is less common in ACC than in many head-and-neck cancers), and whether the cancer has spread to distant organs (M). Beyond the formal stage, two features carry special weight in ACC. The first is perineural invasion — whether, and how extensively, the cancer is tracking along nerves. Because this spread is microscopic and can extend far from the visible tumor, it directly shapes how widely surgeons and radiation oncologists must treat, and named-nerve involvement is specifically noted. The second is the tumor's growth pattern under the microscope (its histologic grade); a 'solid' pattern tends to behave more aggressively than the classic lace-like patterns. A further reality of ACC is its very long timeline: it can recur or appear in the lungs many years after treatment, so distant spread is monitored over a long period, and the lungs — its favored site of spread — are imaged. The practical questions that guide care are: how large and extensive is the tumor, is it involving nerves and how far, can it be removed with clear margins, what is its grade, and has it spread.
| Staged by the TNM system appropriate to its location (most often head-and-neck salivary TNM) — tumor size and extent (T), lymph nodes (N), distant spread (M) — with grade and the presence of nerve invasion strongly influencing treatment | What it generally means |
|---|---|
| Early, localized | A smaller tumor confined to the gland; treated with complete surgery, usually followed by radiation because of ACC's tendency to leave microscopic disease along nerves. |
| Locally advanced | A larger tumor, or one tracking along nerves or invading nearby structures; treated with surgery and radiation, with particle-beam radiation considered when extra precision or dose is needed. |
| Unresectable / delicate location | A tumor that can't be safely removed or sits near critical structures such as the eye or skull base; radiation — often proton or neutron therapy — becomes the main treatment. |
| Metastatic | Cancer that has spread, most often to the lungs and frequently years later; because it usually grows slowly, it is sometimes watched, with focused radiation or other therapy for problem spots. |
The standard of care
Adenoid Cystic Carcinoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Complete surgical removal
Taking out the tumor with a margin of healthy tissue is the foundation of treatment for disease that can be removed; surgeons aim to follow and clear the nerves the cancer may be tracking along.
Postoperative radiation
Radiation after surgery is standard for most ACC because the cancer so often leaves microscopic disease behind, especially along nerves; it treats the tumor bed and the paths of nearby nerves to lower the chance of recurrence.
Definitive radiation for unresectable disease
When a tumor can't be safely removed, radiation — often using precise particle beams — becomes the main treatment, controlling the cancer and relieving symptoms.
Particle-beam radiation (neutrons or protons)
Because ACC is relatively resistant to ordinary treatment, neutron therapy (more biologically powerful) and proton therapy (more precise, sparing nearby structures) are used at specialized centers for selected tumors, particularly near the eye or skull base.
Long-term surveillance
Because ACC can recur or spread to the lungs many years later, follow-up — including periodic chest imaging — continues for a long time so that a recurrence or new deposit is found while it is small.
Systemic therapy and trials for advanced disease
Ordinary chemotherapy has limited effect, so for progressing metastatic disease, targeted drugs and clinical trials aimed at the molecular changes in ACC are important options.
How radiation treatment works
Radiation therapy treats adenoid cystic carcinoma by delivering precisely aimed beams of energy that damage the DNA inside tumor cells so they can no longer grow and divide. It is an essential partner to surgery in this cancer because of ACC's defining behavior: rather than staying within the visible tumor, it tracks along the sheaths of nerves and infiltrates surrounding tissue, leaving microscopic disease that extends well beyond what a surgeon can see or feel. If only the obvious tumor were removed, those extensions — particularly along nerves — could be left behind and seed a recurrence. Radiation treats a wider zone, deliberately including the paths of the nerves the cancer may be following, sterilizing that microscopic disease so the cancer is far less likely to return at the original site. This is why radiation after surgery is standard for most adenoid cystic carcinomas, even when the surgeon removes all visible tumor. When a tumor cannot be safely removed — for instance, when it is wrapped around critical nerves or sits near the eye or skull base — radiation becomes the main treatment. A particular challenge is that ACC is relatively resistant to ordinary radiation, which has driven the use of specialized particle beams. Neutron therapy is more biologically powerful than standard X-rays and has long been studied for inoperable salivary ACC; proton therapy deposits its dose at a precise depth and stops, allowing a high dose to the tumor while sparing the eye, optic nerves, and brain; and carbon-ion therapy combines precision with greater biological power against resistant tumors. The choice among these depends on the tumor's location, whether it was removed, and access to specialized centers. Modern photon techniques such as intensity-modulated radiation also shape the dose tightly around the target and the involved nerves while protecting nearby salivary tissue and the spinal cord. Radiation has a further role beyond the original site: because ACC tends to spread slowly to a limited number of lung deposits, focused stereotactic body radiation can ablate those spots without surgery.
The main ways radiation is delivered for adenoid cystic carcinoma:
Postoperative photon radiation (IMRT)
Intensity-modulated photon radiation shapes the dose tightly around the tumor bed and the paths of involved nerves while sparing nearby structures such as the spinal cord, eyes, and salivary tissue.
Neutron therapy
Fast-neutron radiation is more biologically powerful than standard X-rays and has long been studied for adenoid cystic carcinoma, which resists ordinary radiation; it is delivered at a small number of specialized centers, especially for inoperable salivary tumors.
Proton therapy
Proton beams deposit their energy at a precise depth and stop, allowing a high dose to the tumor while sparing the eye, optic nerves, brain, and other critical structures — particularly valuable for tumors near the skull base or tear gland.
Carbon-ion therapy (selected centers)
Carbon ions combine precise targeting with greater biological power against resistant tumors, and are used for selected adenoid cystic carcinomas at the few centers worldwide that offer them.
Stereotactic body radiation (SBRT) for metastases
Focused, high-dose radiation can ablate a limited number of lung deposits without surgery, fitting ACC's tendency to spread slowly to a few spots.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Surgery plus radiation improves local control: Because adenoid cystic carcinoma so often leaves microscopic disease along nerves, adding radiation after surgery improves control at the original site, making combined treatment the standard for most resectable tumors.[1]
Postoperative radiotherapy outcome series in ACC
Particle-beam radiation for a resistant cancer: Neutron, proton, and carbon-ion therapies have been studied to overcome ACC's relative resistance to ordinary radiation, offering better control for inoperable tumors and those near the eye or skull base where precision is critical.[2]
Particle-therapy studies in adenoid cystic carcinoma
Targeted therapies for advanced disease: Since ordinary chemotherapy has limited effect, research is testing targeted drugs aimed at the molecular changes that drive adenoid cystic carcinoma, with clinical trials an important option for slowly progressing metastatic disease.[3]
Targeted-therapy clinical trials in ACC
Common questions
Why does adenoid cystic carcinoma need radiation even when the surgeon removes the whole tumor? Because of its signature behavior: ACC tracks along the sheaths of nerves and infiltrates the surrounding tissue, leaving microscopic disease that extends well beyond the visible lump — often invisible at surgery. If only the obvious tumor is removed, those extensions, especially along nerves, can be left behind and cause the cancer to return. Radiation after surgery treats a wider zone, deliberately including the paths of nearby nerves, to sterilize that microscopic disease and greatly lower the chance of recurrence. This is why combined surgery and radiation is the standard approach for most adenoid cystic carcinomas, even when the operation appears complete.
Why is this cancer sometimes treated with neutrons or protons instead of ordinary radiation? Adenoid cystic carcinoma is relatively resistant to ordinary X-ray radiation, which has led to the use of specialized particle beams. Neutron therapy is more biologically powerful than standard radiation and has long been studied for salivary ACC that can't be removed. Proton therapy deposits its energy at a precise depth and then stops, which lets doctors give a high dose to the tumor while sparing nearby critical structures such as the eye, optic nerves, and brain — especially important for tumors near the tear gland or skull base. Carbon-ion therapy combines both advantages. These are offered at a limited number of specialized centers, and whether one is right depends on the tumor's location and whether it was removed.
Why do I need follow-up for so many years? Adenoid cystic carcinoma is unusual in how slowly and persistently it behaves. It can come back at the original site, or appear in the lungs, many years — sometimes a decade or more — after the first treatment. Because of this very long timeline, follow-up continues for a long period and usually includes periodic chest imaging, since the lungs are its favored site of spread. The advantage of this slow pace is that even when ACC does spread, it often grows gradually, so deposits caught while small can sometimes be controlled with focused radiation or other treatment, and long-term monitoring directly improves the chance of keeping the disease in check.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.